Treatment Of Suicidal Ideation Or Behavior Using Inhibitors Of Nicotinic Acetylcholine Receptors

Abstract

The invention concerns methods of treating suicidal ideation or behavior in a subject in need thereof, comprising decreasing endogenous nicotinic acetylcholine receptor (nAChR) activity in the subject; therapeutic packages for treating suicidal ideation or behavior; and methods for determining the efficacy of a treatment for suicidal ideation or behavior. In some embodiments, the treatment methods comprise administering to the subject an effective amount of an inhibitor of a nAChR, such as a lithium compound, mecamylamine, clozapine, or asenapine.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Aug 18, 2011
  • Application: Oct 15, 2010
    WO US 2010/0052949 W
  • Priority: Oct 16, 2009
    US US 25234309 P

Sign in to the Lens

Release 5.10.0: Improved patent search performance, saved query alerts, increased user privacy and more!

Improved Search Performance

Upgraded patent search index servers to improve search performance.

Saved Query Alerts.

Improvements to in saved query alerts emails and better formatting of links.

Increased User Privacy.

Removed Google Maps dependency in a Patents Family page.